Phrontline Biopharma

BiotechnologyAngelShanghai, Chinaphrontlinebio.com

Latest round

Angel

Last raised

Jun 2022

Total raised

Undisclosed

Investors

1

About Phrontline Biopharma

, trading as Phrontline Biopharma, is a biotechnology company that focuses on developing ADCs for the tumor field. The team members have more than 10 years of experience in ADC design and development. The founder, Zaoyuan Chen, has led the development of more than 10 ADC drug pipelines. The company is committed to optimizing dual targeting in ADC. The science and technology platform includes Synergy in Tumor MicroEnvironment (SynTume) and Bispecific dual payload ADCs (Two By Two ADC). Its dual payload platform can prolong drug response. The company generates revenue by providing research and development services for antibody-drug conjugates(ADCs).

Who invested in Phrontline Biopharma

1 investor across 1 round

See all investors in Phrontline Biopharma

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Jun 1, 2022

    Amount

    Undisclosed

    Investors

    Locked

Questions about Phrontline Biopharma

Who invested in Phrontline Biopharma?

Phrontline Biopharma has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Phrontline Biopharma raised?

Phrontline Biopharma has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Phrontline Biopharma last raise money?

Phrontline Biopharma's most recent round on record is a Angel, in Jun 2022.

What does Phrontline Biopharma do?

, trading as Phrontline Biopharma, is a biotechnology company that focuses on developing ADCs for the tumor field.

Where is Phrontline Biopharma headquartered?

Phrontline Biopharma is headquartered in Shanghai, China.

Which VCs invest in companies like Phrontline Biopharma?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Phrontline Biopharma's stage. Their profiles are linked below.

Raising like Phrontline Biopharma? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.